Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

0.3600 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anebulo Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 31, 2024

Via Benzinga

ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024 ↗

May 15, 2024

ANEB stock results show that Anebulo Pharmaceuticals beat analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates

May 15, 2024

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says ↗

September 18, 2023

H.C.

Via Benzinga

Anebulo Pharmaceuticals: Q3 Earnings Insights ↗

May 11, 2023

Via Benzinga

Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug ↗

February 14, 2024

Substance use disorder-focused biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported on Tuesday second quarter financial results for the three months ended Dec. 31, 2023, The...

Via Benzinga

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates

February 13, 2024

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 21, 2023

Via Benzinga

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates

November 14, 2023

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 17, 2023

Via Benzinga

Anebulo Pharmaceuticals Announces New CEO

October 06, 2023

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors

October 06, 2023

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates

September 20, 2023

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences

August 30, 2023

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 ↗

September 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 22, 2023

Via Benzinga

Anebulo Receives Positive Feedback From FDA On Path To Phase 3 Trial Of Its Drug For Acute Cannabinoid Intoxication ↗

August 21, 2023

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) announced positive feedback from the United States Food and Drug Administration following a type B meeting in July.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 21, 2023

Via Benzinga

Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension

August 21, 2023

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Antidote For THC? Anebulo Releases Positive Clinical Data Showing Potential Of Its Drug For Treatment Of Acute Cannabinoid Intoxication ↗

March 29, 2023

Anebulo Pharmaceuticals, Inc.

Via Benzinga

Latest Executive Changes In Marijuana Industry, New Appointments & Resignations ↗

March 13, 2023

As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari

Via Benzinga

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 07, 2023

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the...

Via Benzinga

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates

February 10, 2023

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Acute Cannabinoid Intoxication: This Pharma Company's Clinical Trials To Reduce And Treat Symptoms ↗

January 09, 2023

Anebulo Pharmaceuticals, Inc.

Via Benzinga

Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 30, 2023

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the stock with a Buy rating and a $3.30 price target.

Via Benzinga

Anebulo Pharmaceuticals Announces Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication

January 09, 2023

From Anebulo Pharmaceuticals, Inc.

Via Business Wire

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗

December 06, 2022

Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.